两部门:确保今年3月底前完成疫苗追溯体系建设

2020-01-04 佚名 人民网

据国家药品监督管理局官方网站消息,1月3日下午,国家药监局、国家卫生健康委联合召开推进疫苗信息化追溯体系建设工作电视电话会议。会议要求,各相关单位要进一步密切配合、协同推进、倒排时间、分解任务、明确责任、督促落实,确保今年3月底之前完成疫苗追溯体系建设任务,实现全部疫苗产品来源可查、去向可追、责任可究。国家药监局药品监管司相关负责人要求,各有关省药监局要督促疫苗上市许可持有人落实疫苗信息化追溯系统

据国家药品监督管理局官方网站消息,1月3日下午,国家药监局、国家卫生健康委联合召开推进疫苗信息化追溯体系建设工作电视电话会议。会议要求,各相关单位要进一步密切配合、协同推进、倒排时间、分解任务、明确责任、督促落实,确保今年3月底之前完成疫苗追溯体系建设任务,实现全部疫苗产品来源可查、去向可追、责任可究。

国家药监局药品监管司相关负责人要求,各有关省药监局要督促疫苗上市许可持有人落实疫苗信息化追溯系统建设主体责任,上市许可持有人赋码、扫码和数据上传,须严格遵照国家局发布的标准,并做好追溯数据维护、及时上传至协同平台,以保证疫苗追溯信息可联通、可校验。无疫苗生产企业的省份要重点督促配送单位、疾控机构与协同平台实现数据对接。

国家卫生健康委疾控局负责人要求各省卫生健康部门要将疫苗追溯体系建设与免疫规划系统建设相结合,加大基层单位信息化系统建设力度;要加强对各级疾控机构的指导和监督,督促试点省份疾控机构信息化系统尽快与协同平台实现对接并传输数据。

国家药监局副局长陈时飞指出,当前,疫苗信息化追溯体系建设已经进入攻坚阶段,各省要提高对疫苗追溯体系建设重要性和紧迫性的认识,从讲政治的高度,把疫苗信息化追溯体系建设放在当前监管工作的重要位置,优先安排,抓紧部署;要细化工作任务、明确责任分工、压实工作责任;要通过各方协调配合形成工作合力,特别是各省药监局与卫生健康部门要紧密配合,推动系统对接工作顺利开展,并最大限度运用好追溯信息。

陈时飞还要求,在积极推进疫苗追溯体系建设的同时,各省药品监管部门还要落实法规要求全面加强疫苗质量监管,严惩违法违规行为,提升应急处置能力,不断加强疫苗监管能力建设。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2023433, encodeId=d1632023433e0, content=<a href='/topic/show?id=0f8f946404d' target=_blank style='color:#2F92EE;'>#追溯体系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94640, encryptionId=0f8f946404d, topicName=追溯体系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Jul 27 11:55:00 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675443, encodeId=0e2916e544380, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Mon Mar 30 06:55:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967760, encodeId=d3a4196e760d1, content=<a href='/topic/show?id=6807e053550' target=_blank style='color:#2F92EE;'>#疫苗追溯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70535, encryptionId=6807e053550, topicName=疫苗追溯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sun Aug 09 01:55:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690019, encodeId=f5b9169001988, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Tue May 26 13:55:00 CST 2020, time=2020-05-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2023433, encodeId=d1632023433e0, content=<a href='/topic/show?id=0f8f946404d' target=_blank style='color:#2F92EE;'>#追溯体系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94640, encryptionId=0f8f946404d, topicName=追溯体系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Jul 27 11:55:00 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675443, encodeId=0e2916e544380, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Mon Mar 30 06:55:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967760, encodeId=d3a4196e760d1, content=<a href='/topic/show?id=6807e053550' target=_blank style='color:#2F92EE;'>#疫苗追溯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70535, encryptionId=6807e053550, topicName=疫苗追溯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sun Aug 09 01:55:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690019, encodeId=f5b9169001988, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Tue May 26 13:55:00 CST 2020, time=2020-05-26, status=1, ipAttribution=)]
    2020-03-30 日月
  3. [GetPortalCommentsPageByObjectIdResponse(id=2023433, encodeId=d1632023433e0, content=<a href='/topic/show?id=0f8f946404d' target=_blank style='color:#2F92EE;'>#追溯体系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94640, encryptionId=0f8f946404d, topicName=追溯体系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Jul 27 11:55:00 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675443, encodeId=0e2916e544380, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Mon Mar 30 06:55:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967760, encodeId=d3a4196e760d1, content=<a href='/topic/show?id=6807e053550' target=_blank style='color:#2F92EE;'>#疫苗追溯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70535, encryptionId=6807e053550, topicName=疫苗追溯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sun Aug 09 01:55:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690019, encodeId=f5b9169001988, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Tue May 26 13:55:00 CST 2020, time=2020-05-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2023433, encodeId=d1632023433e0, content=<a href='/topic/show?id=0f8f946404d' target=_blank style='color:#2F92EE;'>#追溯体系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94640, encryptionId=0f8f946404d, topicName=追溯体系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Mon Jul 27 11:55:00 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675443, encodeId=0e2916e544380, content=<a href='/topic/show?id=a0542111129' target=_blank style='color:#2F92EE;'>#两部门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21111, encryptionId=a0542111129, topicName=两部门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f827226538, createdName=日月, createdTime=Mon Mar 30 06:55:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967760, encodeId=d3a4196e760d1, content=<a href='/topic/show?id=6807e053550' target=_blank style='color:#2F92EE;'>#疫苗追溯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70535, encryptionId=6807e053550, topicName=疫苗追溯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sun Aug 09 01:55:00 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690019, encodeId=f5b9169001988, content=<a href='/topic/show?id=e963266341b' target=_blank style='color:#2F92EE;'>#体系建设#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26634, encryptionId=e963266341b, topicName=体系建设)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75d628947085, createdName=ms9203727104890838, createdTime=Tue May 26 13:55:00 CST 2020, time=2020-05-26, status=1, ipAttribution=)]

相关资讯

7地率先试点疫苗追溯,明年3月底实现所有上市疫苗全程可查

就做好疫苗信息化追溯体系建设提出了详细安排。澎湃新闻(www.thepaper.cn)注意到,根据通知要求将在北京、天津、内蒙古、上海、江苏、海南、重庆等7地先行试点,率先完成疫苗信息化追溯体系建设。到明年3月31日前,将实现所有上市疫苗全过程可追溯,确保疫苗最小包装单位可追溯、可核查。根据《国家药监局综合司、国家卫生健康委办公厅关于做好疫苗信息化追溯体系建设工作的通知》(以下简称通知)下发的